Novel Vaccine Design Strategies Against SARS-CoV-2 Variants: From Conserved Region Targeting to Multiepitope Approaches

SARS-CoV-2, the causative agent of COVID-19, represents a significant global health challenge. The continuous emergence of variants with immune-evasion capabilities, particularly Delta, Beta, and Omicron, has raised concerns about the long-term efficacy of current vaccines. These variants harbor mutations in the spike protein that alter viral binding affinity and enable escape from vaccine-induced neutralizing antibodies. This research examines vaccine design strategies targeting breakthrough variants, with particular focus on antibody-tolerant functions and mutational adaptability characteristics. We analyze modifications in spike protein configuration and function, especially within the receptor-binding domain (RBD), which primarily contributes to immune escape. Additionally, we evaluate how these mutations impact vaccine development and propose broad-spectrum protection strategies. By integrating insights from molecular evolution, structural biology, and immunology, this study provides a comprehensive framework for understanding SARS-CoV-2 and offers novel perspectives on future vaccine design. Our findings underscore the importance of developing mutation-responsive vaccines and therapeutic approaches to address continuously evolving viral threats.